No spam - just the good stuff

Subscribe to our newsletter
Hidden
  • News
  • Investor Portal
  • Lifestyle
  • Videos

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

InvestmentInvestor Portal

  • Investment portal
  • Investment portal login
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy
News > Longevity 2020Early access to the treatment of aging: distinguishing rational self-experimentation from arrant foolishness

Early access to the treatment of aging: distinguishing rational self-experimentation from arrant foolishness

Author: Phil Newman  |  Published on: May 1, 2020  |  Last updated: May 10, 2022

Reason

Co-founder and CEO, Repair Biotechnologies & Fight Aging!

Early access to the treatment of aging: distinguishing rational self-experimentation from arrant foolishness


 

Share this article:

Editor's choice

Will proteomics provide the answers to aging and longevity?

Don’t wait for longevity drugs – take action today

Scientific leaders issue global Dublin Longevity Declaration

‘Data-driven health is going to be the biggest revolution in the history of medicine’

Leveraging the past to illuminate longevity for the future

‘It’s always too early to say something’s impossible’

Popular articles

Longevity investment bulletin: NewLimit, ORA, Insilico Medicine and more

Stay cool: the longevity tech that “shows insane promise”

Does SIRT6 hold the key to human longevity?

Tally up! Consumer longevity company lands $10m

Longevity: ‘money-spinning cult’ or the future of health?

Zuzalu: a pop-up city with longevity at its heart

More like this

‘Our vision statement is clear: Expand healthy lifespan for the benefit of all’

Economy

Improving healthspan and longevity can be just like riding a bike

Biotech

‘The longevity revolution has the potential to transform healthcare in our lifetime’

Videos

‘We all play don’t die every day – now let’s get really, really good at it’

Economy

Going for gold: new International Roundtable aims to set gold standard for longevity clinics

Economy

How sports medicine can maximize the longevity runway

Economy

Are supplements the key to unlocking healthy longevity?

Economy

‘It’s worth the hype – longevity is going to explode’

Features

‘I want medical tourism to be open to everyone, forever’

Features

‘We are information machines – and it’s time to renew the code.’

Investment

‘It’s always too early to say something’s impossible’

Videos

‘We’re at the longevity inflection point – and the explosion is coming.’

Features

Longevity to a sirtuin extent

Videos

‘Longevity is the biggest revolution in the history of Homo sapiens – don’t die!’

Features

Longevity: This time it’s personal

Supplements

SIRT6: The protein that talks the talk and walks the walk

Videos

Find us here ...

Subscribe to our newsletter

Hidden

News

  • Home
  • Biotech
  • Investment
  • Diagnostics
  • Agetech
  • Supplements
  • Innovation
  • AI/Digital
  • Economy

Investment

  • Investment portal
  • Investment portal login
  • Raise finance

Lifestyle

  • Home
  • Supplements
  • Self-testing
  • Exercise
  • Nutrition
  • Tech
  • Mental wellness
  • Product reviews

More

  • Contact
  • Features
  • Editorial Policy
  • Privacy Policy
  • Cookie Policy
  • Conditions of Business
  • Terms and Conditions
  • Copyright Policy
© Copyright 2023 FIRST LONGEVITY Limited. All rights reserved. FIRST LONGEVITY
The information included in this website is for informational purposes only: its purpose is to promote a broad consumer understanding a knowledge of various health topics. It is not intended to be a substitute for professional medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health care provider with any questions you may have regarding a medical condition or treatment and before undertaking a new health care regimen, and never disregard professional medical advice or delay in seeking it because of something you have read on this website.

DISCLAIMER FOR U.S. BASED INVESTORS
The Agent of First Longevity Limited in the United States is Marco Polo Securities Inc, a non-affiliated broker-dealer registered with the US Securities and Exchange Commission. The activities of First Longevity Limited in the United States will be affected only to the extent permitted by Rule 15a-6 under the US Securities Exchange Act of 1934 and in accordance with the Services Agreement entered into between First Longevity Limited and Marco Polo Securities Inc with respect thereto. Contact at Marco Polo Securities is clientservices@mpsecurities.com; 1-347-745-6448.